Either of two phenomena may be at work -- the "placebo effect" or the "post hoc, ergo propter hoc" (after this, therefore because of this) fallacy. Some of the most iconic over-the-counter name-brand ...
The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold medicines from the market, after the agency's scientists concluded that the ...
WASHINGTON (AP) — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines ...
THURSDAY, Nov. 7, 2024 (HealthDay News) -- More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug ...
In a long-sought move, the Food and Drug Administration on Thursday formally began the process of abandoning oral doses of a common over-the-counter decongestant, which the agency concluded last year ...
That familiar red pill you reach for when congestion strikes may not be delivering the relief you expect. In a significant development for consumers nationwide, the Food and Drug Administration has ...
On Thursday the Food and Drug Administration announced it is proposing to remove oral phenylephrine as an active ingredient that can be used in over-the-counter monograph drug products for the ...
Hisham Al-Obaidi does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
WASHINGTON — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results